Suppr超能文献

相似文献

1
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.
Cancer Cell. 2014 Aug 11;26(2):222-34. doi: 10.1016/j.ccr.2014.06.026.
3
Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
Oncotarget. 2016 Mar 15;7(11):12554-67. doi: 10.18632/oncotarget.7275.
4
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.
Nucleic Acids Res. 2017 May 5;45(8):4452-4462. doi: 10.1093/nar/gkx039.
5
MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.
PLoS One. 2014 Jun 26;9(6):e100693. doi: 10.1371/journal.pone.0100693. eCollection 2014.
6
Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.
Mol Cell Biol. 2014 Feb;34(3):522-32. doi: 10.1128/MCB.00612-13. Epub 2013 Nov 25.
8
COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Nature. 2011 May 15;474(7351):403-6. doi: 10.1038/nature10005.
9
The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2.
PLoS One. 2012;7(5):e37151. doi: 10.1371/journal.pone.0037151. Epub 2012 May 17.
10
Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Biochim Biophys Acta. 2011 Oct;1813(10):1767-76. doi: 10.1016/j.bbamcr.2011.06.004. Epub 2011 Jun 29.

引用本文的文献

1
CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.
J Transl Int Med. 2025 Jun 20;13(3):267-280. doi: 10.1515/jtim-2025-0029. eCollection 2025 Jun.
2
COP1 Deficiency in BRAF Melanomas Confers Resistance to Inhibitors of the MAPK Pathway.
Cells. 2025 Jun 25;14(13):975. doi: 10.3390/cells14130975.
3
LCN2 promotes focal adhesion formation and invasion by stimulating c-Src activation.
J Cell Sci. 2025 Jun 1;138(11). doi: 10.1242/jcs.263663. Epub 2025 Jun 5.
4
CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective.
Cells. 2025 Jan 7;14(2):63. doi: 10.3390/cells14020063.
5
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.
Cell Death Discov. 2024 Oct 28;10(1):454. doi: 10.1038/s41420-024-02220-y.
6
Dihydroartemisinin Modulates Prostate Cancer Progression by Regulating Multiple Genes the Transcription Factor NR2F2.
Curr Pharm Biotechnol. 2025;26(6):935-955. doi: 10.2174/0113892010311317240919061821.
7
ETS1 Function in Leukemia and Lymphoma.
Adv Exp Med Biol. 2024;1459:359-378. doi: 10.1007/978-3-031-62731-6_16.
9
USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity.
Biomolecules. 2023 Oct 1;13(10):1475. doi: 10.3390/biom13101475.
10
Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition.
Sci Rep. 2023 Jun 8;13(1):9320. doi: 10.1038/s41598-023-36512-7.

本文引用的文献

1
Spotlight on the role of COP1 in tumorigenesis.
Nat Rev Cancer. 2012 Jun 7;12(7):455-64. doi: 10.1038/nrc3271.
3
Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study.
Clin Cancer Res. 2011 Nov 1;17(21):6905-13. doi: 10.1158/1078-0432.CCR-11-0288. Epub 2011 Oct 25.
4
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.
Clin Cancer Res. 2011 Nov 1;17(21):6897-904. doi: 10.1158/1078-0432.CCR-11-0070. Epub 2011 Sep 8.
7
Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Biochim Biophys Acta. 2011 Oct;1813(10):1767-76. doi: 10.1016/j.bbamcr.2011.06.004. Epub 2011 Jun 29.
8
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function.
Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):413-26. doi: 10.1038/nrm3141.
10
COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Nature. 2011 May 15;474(7351):403-6. doi: 10.1038/nature10005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验